Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P17
Within normal range
vs 2Y Ago
-8.9x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -50.77% |
| Q3 2025 | -112.00% |
| Q2 2025 | -135.32% |
| Q1 2025 | 238.63% |
| Q4 2024 | 149.02% |
| Q3 2024 | 18.73% |
| Q2 2024 | 6.60% |
| Q1 2024 | -0.24% |
| Q4 2023 | 5.69% |
| Q3 2023 | 0.68% |
| Q2 2023 | -8.65% |
| Q1 2023 | -5.45% |
| Q4 2022 | -14.55% |
| Q3 2022 | -4.15% |
| Q2 2022 | -12.05% |
| Q1 2022 | -3.91% |
| Q4 2021 | -17.71% |
| Q3 2021 | -9.63% |
| Q2 2021 | -57.54% |
| Q1 2021 | 3.62% |
| Q4 2020 | -86.91% |
| Q3 2020 | -18.35% |
| Q2 2020 | -25.69% |
| Q1 2020 | 0.00% |